Brussels, 15/11/2012 (Agence Europe) - In view of the upcoming discussions at the European Parliament on new legislation on clinical trials, the European Federation of Pharmaceutical Industries and Associations (EFPIA) is calling on all stakeholders to collaborate to improve the transparency recommended by the European Commission. The transparency of data and the sharing of results is one of the key elements of the Commission proposals to reinvigorate clinical research (see EUROPE 10657)....